BaseLaunch Investor
The BaseLaunch accelerator supports carefully selected ventures over the course of 15 months and runs in two phases. It provides non-dilutive funding, no strings attached access to its Healthcare Partners, knowledge from highly experienced advisors, as well as a state-of-the-art infrastructure. Furthermore, Baselaunch embeds the ventures deeply within the Basel region, one of Europe’s finest biotech ecosystem. Baselaunch is backed by five industry leaders — Johnson & Johnson Innovation, Novartis Venture Fund, Pfizer, Roche and Roivant Sciences — as well as by other public and private partners.
Invests into
Investor Type:
Venture Funds
Employee Number:
1-10
Headquarters:
Allschwil, Basel-Landschaft, Switzerland, Europe
Founded Date:
2017-01-01
Industry:
Biopharma & Life Science Tools
Number:
68
City:
Allschwil
Country:
Switzerland
Phone Number:
41 61 564 35 55
Leaders:
Ekkehard Moessner
Income:
$2.5m.
Investor:
BaseLaunch, Versant Ventures, Novartis Venture Fund, Pfizer, Roche
Number Of Investment/Funding Rounds:
13
Region:
Basel-Landschaft